The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Metabolic regulation of NLRP 3
Open accessAbstract
Summary: A shift in our understanding of macrophage biology has come about as a result of recent discoveries in the area of metabolic reprogramming of macrophages. The NLRP 3 inflammasome drives the activation of caspase‐1, leading to the production of IL ‐1β, IL ‐18, and a type of cell death termed pyroptosis. The NLRP 3 inflammasome has been shown to sense metabolites such as palmitate, uric acid, and cholesterol crystals and is inhibited by ketone bodies produced during metabolic flux. The NLRP 3 inflammasome has also been shown to be regulated by mitochondrial reactive oxygen species and components of glycolysis, such as Hexokinase. Here, we review these findings and discuss their importance for inflammation and furthermore discuss potential therapeutic benefits of targeting NLRP 3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A number of molecules in lipid metabolism pathways have been identified to regulate NLRP3 inflammasome activation [41].”
From HIV-TAT dysregulates microglial lipid metabolism through SREBP2/miR-124 axis: Implication of lipid droplet accumulation microglia in NeuroHIV (2025) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
RETRACTED: mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
Moon, J.-S., Hisata, S., Park, M. A., DeNicola, G. M., Ryter, S. W., Nakahira, K., & Choi, A. M. K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.046 · Cited by 379
RetractedMoon, J.-S., Nakahira, K., Chung, K.-P., DeNicola, G. M., Koo, M. J., Pabón, M. A., Rooney, K. T., Yoon, J.-H., Ryter, S. W., Stout-Delgado, H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4153 · Cited by 291
RetractedUCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
Moon, J.-S., Lee, S., Park, M.-A., Siempos, I. I., Haslip, M., Lee, P. J., Yun, M., Kim, C. K., Howrylak, J., Ryter, S. W., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78253 · Cited by 238
RetractedMartinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Self-citationCaspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686
Mitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Self-citationThioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Flagged first, then by citations
Cited by
Sorted by citations
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang, Y., Wang, H., Kouadir, M., Song, H., & Shi, F. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1413-8 · Cited by 1,326
Reactive Oxygen Species: Drivers of Physiological and Pathological Processes
Checa, J., & Aran, J. M. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s275595 · Cited by 1,068
Interleukin-18 in Health and Disease
Yasuda, K., Nakanishi, K., & Tsutsui, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030649 · Cited by 583
A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases
Barnett, K. C., Li, S., Liang, K., & Ting, J. P.-Y. (2023) · Cell · doi:10.1016/j.cell.2023.04.025 · Cited by 458
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J. R., & Gaskill, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 328
PANoptosis : Mechanisms, biology, and role in disease
Sun, X., Yang, Y., Meng, X., Li, J., Liu, X., & Liu, H. (2023) · Immunological Reviews · doi:10.1111/imr.13279 · Cited by 333
Bonnet, F., & Scheen, A. J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.09.005 · Cited by 322
Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis
Tabas, I. A., & Bornfeldt, K. (2020) · Circulation Research · doi:10.1161/circresaha.119.315939 · Cited by 253
Ma, Q. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000629 · Cited by 260
NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma
McKee, C. M., & Coll, R. C. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0720-513r · Cited by 246
Programmed cell death in atherosclerosis and vascular calcification
Li, M., Wang, Z., Fang, L., Cheng, S.-Q., Wang, X., & Liu, N. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04923-5 · Cited by 243
Inhibition of glycolysis alleviates lipopolysaccharide‐induced acute lung injury in a mouse model
Zhong, W., Yang, H., Guan, X., Xiong, J., Sun, C., Zhang, C., Luo, X., Zhang, Y., Zhang, J., Duan, J., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27261 · Cited by 216
The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
Meyers, A. K., & Zhu, X. (2020) · Cells · doi:10.3390/cells9081808 · Cited by 207
Yu, H., Chang, Q., Sun, T., He, X., Wen, L., An, J., Feng, J., & Zhao, Y. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102032 · Cited by 216
Zhang, X., Wang, R., Hu, D., Sun, X., Fujioka, H., Lundberg, K., Chan, E. R., Wang, Q., Xu, R., Flanagan, M. E., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb8680 · Cited by 200
Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP/NLRP3 Pathway
An, X., Zhang, Y., Cao, Y., Chen, J., Qin, H., & Yang, L. (2020) · Nutrients · doi:10.3390/nu12051516 · Cited by 192
Hexokinase 1 cellular localization regulates the metabolic fate of glucose
Jesus, A. D., Keyhani‐Nejad, F., Pusec, C. M., Goodman, L., Geier, J., Stoolman, J. S., Stanczyk, P. J., Nguyen, T., Xu, K., Suresh, K. V., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.028 · Cited by 189
Renaudin, F., Orliaguet, L., Castelli, F. A., Fenaille, F., Prignon, A., Alzaïd, F., Combes, C., Delvaux, A., Adimy, Y., Cohen-Solal, M. E., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217342 · Cited by 189
NLRP3 inflammasome activation in inflammaging
Latz, E., & Duewell, P. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.001 · Cited by 174
Marrocco, A., & Ortiz, L. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.936167 · Cited by 173
Finucane, O. M., Sugrue, J. A., Rubio‐Araiz, A., Guillot‐Sestier, M., & Lynch, M. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-40619-1 · Cited by 155
Luo, X., Bao, X., Weng, X., Bai, X., Yi, F., Huang, J., Liu, S., Jia, H., & Yu, B. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120064 · Cited by 156
Zhang, M., Zheng, Y., Sun, Y., Li, S., Chen, L., Jin, X., Hou, X., Liu, X., Chen, Q., Li, J., et al. (2019) · Theranostics · doi:10.7150/thno.33178 · Cited by 136
Han, Y., Sun, W., Ren, D., Zhang, J., He, Z., Fedorova, J., Sun, X., Han, F., & Li, J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101538 · Cited by 133
Tan, Y.-F., Wang, M., Chen, Z., Wang, L., & Liu, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2431-2 · Cited by 132
Cui, D., Liu, S., Tang, M., Lu, Y., Zhao, M., Mao, R., Wang, C., Yuan, Y., Li, L., Chen, Y., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153111 · Cited by 129
Lee, H., Fessler, M. B., Qu, P., Heymann, J. A. W., & Kopp, J. B. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01921-7 · Cited by 124
Ahechu, P., Zozaya, G., Martí, P., Hernández-Lizoáin, J. L., Baixauli, J., Unamuno, X., Frühbeck, G., & Catalán, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02918 · Cited by 131
Targeting Innate Immunity in Cancer Therapy
Rameshbabu, S., Labadie, B. W., Argulian, A., & Patnaik, A. (2021) · Vaccines · doi:10.3390/vaccines9020138 · Cited by 121
Targeting NLRP3 Inflammasome Activation in Severe Asthma
Theofani, E., Semitekolou, M., Morianos, I., Samitas, Κ., & Xanthou, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101615 · Cited by 122
Rubio‐Araiz, A., Finucane, O. M., Keogh, S., & Lynch, M. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1281-7 · Cited by 117
Kostopoulou, M., Nikolopoulos, D., Parodis, I., & Bertsias, G. K. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161118666191227101636 · Cited by 114
Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders
Wani, K., AlHarthi, H., Alghamdi, A. A., Sabico, S., & Al‐Daghri, N. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020511 · Cited by 118
Inflammasomes and Atherosclerosis: a Mixed Picture
Tall, A. R., & Bornfeldt, K. (2023) · Circulation Research · doi:10.1161/circresaha.123.321637 · Cited by 112
Rong, S., Wan, D., Fan, Y., Liu, S., Sun, K., Huo, J., Zhang, P., Li, X., Xie, X., Wang, F., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00856 · Cited by 106
Pandey, A., Li, Z., Gautam, M., Ghosh, A., & Man, S. M. (2024) · Immunological Reviews · doi:10.1111/imr.13406 · Cited by 120
Origins and diversity of macrophages in health and disease
Sreejit, G., Fleetwood, A. J., Murphy, A. J., & Nagareddy, P. R. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1222 · Cited by 112
Increasing complexity of NLRP3 inflammasome regulation
Moretti, J., & Blander, J. M. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0520-104rr · Cited by 107
The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout
Szekanecz, Z., Szamosi, S., Kovács, G. E., Kocsis, E., & Benkő, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.01.031 · Cited by 101
The Role of HDAC6 in Autophagy and NLRP3 Inflammasome
Chang, P., Li, H., Hu, H., Li, Y., & Wang, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.763831 · Cited by 103
Yu, Q., Shi, H., Ding, Z., Wang, Z., Yao, H., & Lin, R. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-00954-9 · Cited by 105
Role of NLRP3 Inflammasome in Rheumatoid Arthritis
Yin, H., Liu, N., Sigdel, K. R., & Duan, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931690 · Cited by 103
Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis
Clayton, S. A., MacDonald, L., Kurowska‐Stolarska, M., & Clark, A. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673916 · Cited by 100
Hu, Y., Shi, Y., Chen, H., Tao, M., Zhou, X., Li, J., Ma, X., Wang, Y., & Liu, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.858494 · Cited by 98
The role of uric acid in inflammasome-mediated kidney injury
Braga, T. T., Foresto‐Neto, O., & Câmara, N. O. S. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000619 · Cited by 91
HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways
Bao, C., Zhu, S., Song, K., & He, C. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00943-y · Cited by 93
Can the emerging field of immunometabolism provide insights into neuroinflammation?
Lynch, M. A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101719 · Cited by 88
Inflammation and Cardiovascular Disease: The Future
Arnold, N., Lechner, K., Waldeyer, C., Shapiro, M. D., & Köenig, W. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.50 · Cited by 93
P2Y14 receptor has a critical role in acute gouty arthritis by regulating pyroptosis of macrophages
Li, H., Jiang, W., Ye, S., Zhou, M., Liu, C., Yang, X., Hao, K., & Hu, Q. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2609-7 · Cited by 87
Pnpt1 mediates NLRP3 inflammasome activation by MAVS and metabolic reprogramming in macrophages
Hsu, C. G., Li, W., Sowden, M. P., Chávez, C. L., & Berk, B. C. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00962-2 · Cited by 84
Dinarello, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12624 · Cited by 82
NLRP3 inflammasome and IL-1β pathway in type 2 diabetes and atherosclerosis: Friend or foe?
Chen, X., Zhang, D., Li, Y., Wang, W., Bei, W., & Guo, J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105885 · Cited by 84
Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway
Duez, H., & Pourcet, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.630536 · Cited by 85
From Mitochondria to Atherosclerosis: The Inflammation Path
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Talaverón-Rey, M., Suárez-Carrillo, A., Munuera-Cabeza, M., & Sánchez-Alcázar, J. A. (2021) · Biomedicines · doi:10.3390/biomedicines9030258 · Cited by 78
Tassone, E. J., Cimellaro, A., Perticone, M., Hribal, M. L., Sciacqua, A., Andreozzi, F., Sesti, G., & Perticone, F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00098 · Cited by 75
Chang, Y., Yuan, L., Liu, J., Muhammad, I., Cao, C., Shi, C., Zhang, Y., Li, R., Li, C., & Liu, F. (2020) · Veterinary Research · doi:10.1186/s13567-020-00796-8 · Cited by 74
Zhang, Y., Liu, W., Zhong, Y., Li, Q., Wu, M., Yang, L., Liu, X., & Zou, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1806344 · Cited by 73
Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syndrome
O’Neill, B. J. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000569 · Cited by 72
How Mitochondrial Metabolism Contributes to Macrophage Phenotype and Functions
Benmoussa, K., Garaude, J., & Acín‐Pérez, R. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.07.003 · Cited by 69
Frame, J. M., Kubaczka, C., Long, T. L., Esain, V., Soto, R. A., Hachimi, M., Jing, R., Shwartz, A., Goessling, W., Daley, G. Q., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.07.015 · Cited by 68
The Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification
Yu, C., Zhang, C., Kuang, Z., & Zheng, Q. (2020) · Inflammation · doi:10.1007/s10753-020-01357-z · Cited by 67
Liu, X., Wang, Y., Wu, D., Li, S., Wang, C., Han, Z., Wang, J., Wang, K., Yang, Z., & Wei, Z. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01459 · Cited by 67
Qiao, S., Lv, C., Tao, Y., Miao, Y., Zhu, Y., Zhang, W., Sun, D., Yun, X., Xia, Y., Wei, Z., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.033 · Cited by 66
Liu, J., Li, Y., Chen, S., Lin, Y., Lai, H., Chen, B., & Chen, T. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00838 · Cited by 70
Regulation of the NLRP3 Inflammasome by Posttranslational Modifications
Zangiabadi, S., & Sater, A. A. A. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100734 · Cited by 63
Jin, X., Dong, X., Sun, Y., Liu, Z., Liu, L., & Gu, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3711371 · Cited by 61
Zhu, J., Chen, H., Le, Y., Guo, J., Liu, Z., Dou, X., & Lu, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1009229 · Cited by 63
Overcoming Cancer Resistance to Platinum Drugs by Inhibiting Cholesterol Metabolism
Wang, Y., Cai, L., Li, H., Chen, H., Yang, T., Tan, Y., Guo, Z., & Wang, X. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202309043 · Cited by 62
Koselny, K., Mutlu, N., Minard, A. Y., Kumar, A., Krysan, D. J., & Wellington, M. A. (2018) · mBio · doi:10.1128/mbio.01204-18 · Cited by 62
Liu, D., Xiao, Y., Zhou, B., Gao, S., Li, L., Zhao, L., Chen, W., Dai, B., Li, Q., Duan, H., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa473 · Cited by 59
Fu, Q., Zhai, Z., Wang, Y., Xu, L., Jia, P., Xia, P., Liu, C., Zhang, X., Qin, T., & Zhang, H. (2018) · BioMed Research International · doi:10.1155/2018/1294951 · Cited by 59
Jiang, M., Wu, Y., Qi, L., Li, L., Song, D., Gan, J., Li, Y., Ling, X., & Song, C. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109704 · Cited by 58
Le, S., Zhang, H., Huang, X., Chen, S., Wu, J. P., Chen, S., Ding, X., Chen, S., Zhao, J., Xu, H., et al. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420919966 · Cited by 57
Qi, X., Hou, R., Xie, L., Niu, M., Pan, X., & Zhu, X. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1257 · Cited by 55
Microglial Immunometabolism in Alzheimer’s Disease
Shippy, D. C., & Ulland, T. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.563446 · Cited by 56
Cosker, K., Mallach, A., Limaye, J., Piers, T. M., Staddon, J. M., Neame, S. J., Hardy, J., & Pocock, J. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-91207-1 · Cited by 53
Zhong, Z., & Lemasters, J. J. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13877 · Cited by 58
Devi, T. S., Yumnamcha, T., Yao, F., Somayajulu, M., Kowluru, R. A., & Singh, L. P. (2019) · Biology Open · doi:10.1242/bio.038521 · Cited by 58
Yu, Q., Guo, M., Zeng, W., Zeng, M., Zhang, X., Zhang, Y., Zhang, W., Jiang, X., & Yu, B. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.581 · Cited by 52
Chen, A., Chen, Z., Zhou, Y., Wu, Y., Xia, Y., Lu, D., Fan, M., Su, L., Chen, J., Sun, A., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03389-1 · Cited by 52
JQ1 as a BRD4 Inhibitor Blocks Inflammatory Pyroptosis-Related Acute Colon Injury Induced by LPS
Chen, L., Zhong, X., Cao, W., Mao, M., Li, W., Yang, H., Li, M., Shi, M., Zhang, Y., Deng, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.609319 · Cited by 52
Wang, X., Li, X.-L., & Qin, L.-J. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00607-4 · Cited by 51
Crosstalk Between Staphylococcus aureus and Innate Immunity: Focus on Immunometabolism
Horn, C. M., & Kielian, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621750 · Cited by 53
Zhang, T., Ding, S., & Wang, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910866 · Cited by 53
Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview
Gupta, A., Marzook, H., & Ahmad, F. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00821-4 · Cited by 58
Zhang, Z., Li, M., Li, X., Feng, Z., Luo, G., Wang, Y., & Gao, X. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03254-w · Cited by 56
Zhang, Z., Xie, S., Qian, J., Gao, F., Jin, W., Wang, L., Yan, L., Chen, H., Yao, W., Li, M., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04313-1 · Cited by 53
Chen, X., Li, Y., Li, J., Liu, T., Jiang, Q., Hong, Y., Wang, Q., Li, C., Guo, D., & Wang, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114841 · Cited by 48
Liu, J., Wang, C., Li, J., Yu, Y., Liu, Y., Liu, H., Peng, Q., & Guan, X. (2021) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-021-00811-2 · Cited by 47
Vitamin C alleviates hyperuricemia nephropathy by reducing inflammation and fibrosis
Li, H., Liu, X., Lee, M., & Li, H. (2021) · Journal of Food Science · doi:10.1111/1750-3841.15803 · Cited by 46
Danielski, L. G., Giustina, A. D., Bonfante, S., Goldim, M. P. D. S., Joaquim, L. D. S., Metzker, K. L. L., Biehl, E., Vieira, T. C., de Medeiros, F. D., da Rosa, N., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02089-9 · Cited by 43
Zhang, D., He, Y., Ye, X., Cai, Y., Xu, J., Zhang, L., Li, M., Liu, H., Wang, S., & Xia, Z. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13235 · Cited by 41
NLRP3 inflammasome inhibitor cucurbitacin B suppresses gout arthritis in mice
Xue, Y., Li, R., Fang, P., Ye, Z.-Q., Zhao, Y. L., Zhou, Y., Zhang, K., & Li, L. (2021) · Journal of Molecular Endocrinology · doi:10.1530/jme-20-0305 · Cited by 41
Role of Stat3 in NLRP3/caspase‐1‐mediated hippocampal neuronal pyroptosis in epileptic mice
Jiang, Q., Tang, G. Q., Zhong, X., Ding, D., Wang, H., & Li, J. (2021) · Synapse · doi:10.1002/syn.22221 · Cited by 41
Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanism
Magnotti, F., Chirita, D., Dalmon, S., Martin, A., Bronnec, P., Sousa, J., Helynck, O., Lee, W., Kastner, D. L., Chae, J. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111472 · Cited by 42
Meng, J., Li, N., Liu, X., Qiao, S., Zhou, Q., Tan, J., Zhang, T., Dong, Z., Qi, X., Kijlstra, A., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42420 · Cited by 40
Reactive oxygen species trigger inflammasome activation after intracellular microbial interaction
Rosa, C. P., Belo, T. C. A., Santos, N. C. D. M., Silva, E. N., Gasparotto, J., Corsetti, P. P., & de Almeida, L. A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122076 · Cited by 40
Yang, H., Lin, P.-Y., Vadivalagan, C., Lin, Y., Lin, K., & Hseu, Y. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03456-w · Cited by 38
Regulation of NLRPs by reactive oxygen species: A story of crosstalk
Ziehr, B. K., & MacDonald, J. A. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119823 · Cited by 43
Metadata
- Authors
- Hughes, M. M., & O'Neill, L. A. J.
- Affiliations
- Trinity College Dublin (IE)
- Corresponding author
- Hughes, Mark M.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2017-12-16
- Volume
- 281
- Issue
- 1
- Pages
- 88-98
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2778840601
- Cited by
- 311
- References
- 86
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 50 · 2023: 48 · 2022: 49 · 2021: 49 · 2020: 47 · 2019: 18 · 2018: 13 · 2017: 1
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Immunological Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science Foundation Ireland
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- NLRP3 inflammasome, macrophage metabolic reprogramming, caspase-1 activation, IL-1β, IL-18, pyroptosis, palmitate, uric acid, cholesterol crystals, ketone bodies, mitochondrial reactive oxygen species, hexokinase, glycolysis, inflammation, inflammasome inhibition
- MeSH terms
- Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Cholesterol, Hexokinase, Humans, Ketone Bodies, Macrophages, Uric Acid, Reactive Oxygen Species, Palmitic Acid, Caspase 1, Inflammasomes, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review